How to buy InspireMD stock (NSPR)

InspireMD is a medical devices business based in the US. InspireMD shares (NSPR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.00 – an increase of 1.69% over the previous week. InspireMD employs 65 staff and has a trailing 12-month revenue of around $6.8 million.

Our top picks for where to buy InspireMD stock

Buy InspireMD stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

InspireMD stock price (NASDAQ: NSPR)

Use our graph to track the performance of NSPR stocks over time.

InspireMD shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$3.00
52-week range	$1.81 - $3.42
50-day moving average more info button	$2.67
200-day moving average more info button	$2.56
Wall St. target price	$4.75
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.71

Is it a good time to buy InspireMD stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

InspireMD price performance over time

Historical closes compared with the close of $2.98 from 2024-12-19

1 week (2024-12-13)	1.02%
1 month (2024-11-21)	15.50%
3 months (2024-09-20)	7.19%
6 months (2024-06-21)	18.25%

1 year (2023-12-21)	44.66%
2 years (2022-12-21)	198.00%
3 years (2021-12-21)	3.39
5 years (2019-12-20)	14.7

InspireMD financials

Revenue TTM	$6.8 million
Gross profit TTM	$1.1 million
Return on assets TTM	-37.24%
Return on equity TTM	-66.75%
Profit margin	0%
Book value	$1.61
Market Capitalization more info button	$75.4 million

TTM: trailing 12 months

InspireMD share dividends

We're not expecting InspireMD to pay a dividend over the next 12 months.

Have InspireMD's shares ever split?

InspireMD's shares were split on a 1:15 basis on 26 April 2021 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InspireMD shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for InspireMD shares which in turn could have impacted InspireMD's share price.

InspireMD share price volatility

Over the last 12 months, InspireMD's shares have ranged in value from as little as $1.81 up to $3.42. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InspireMD's is 0.928. This would suggest that InspireMD's shares are less volatile than average (for this exchange).

InspireMD overview

InspireMD, Inc. , a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc.

Frequently asked questions

null
What percentage of InspireMD is owned by insiders or institutions?
Currently 16.994% of InspireMD shares are held by insiders and 40.847% by institutions. How many people work for InspireMD?
Latest data suggests 65 work at InspireMD. When does the fiscal year end for InspireMD?
InspireMD's fiscal year ends in December. Where is InspireMD based?
InspireMD's address is: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 What is InspireMD's ISIN number?
InspireMD's international securities identification number is: US45779A8466 What is InspireMD's CUSIP number?
InspireMD's Committee on Uniform Securities Identification Procedures number is: 45779A853